KCNJ10 and autism spectrum disorder: Although no information on the structure-activity relationship for Kir4.1 channel stimulators is available, gain-of-function mutations of the KCNJ10 gene (e.g., R18Q in N-terminus and V84M in TM1 region) reported in patients with autism spectrum disorders may give hints for new drug discovery (70, 72).